Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
Clinical trial NCT01683175 · UNKNOWN
Trial details
- NCT number
- NCT01683175
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2020-10-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.